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Abstract 
Human placenta is a complex and heterogeneous organ interfacing between the mother and the 
fetus that supports fetal development. Alterations to placental structural components are associated 
with various pregnancy complications. To reveal the heterogeneity among various placenta cell 
types in normal and diseased placentas, as well as elucidate molecular interactions within a 
population of placental cells, a new genomics technology called single cell RNA-Seq (or scRNA-
seq) has been employed in the last couple of years. Here we review the principles of scRNA-seq 
technology, and summarize the recent human placenta studies at scRNA-seq level across 
gestational ages as well as in pregnancy complications such as preterm birth and preeclampsia. We 
list the computational analysis platforms and resources available for the public use. Lastly, we 
discuss the future areas of interest for placenta single cell studies, as well as the data analytics 
needed to accomplish them.  
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Introduction 
The placenta is the interface between the mother and the fetus, which mediates the exchange of 
gas, nutrients, waste, and produces hormones and growth factors that support fetal development 
and ensure a healthy pregnancy. Much of the understanding of early stages of human implantation 
and placental development is based on histological analyses of specimens of the Boyd Collection 
and Carnegie Institution of Washington (Hertig 1956; Hamilton et al.1960), as well as anatomical 
studies of species closest to humans (Enders 2007). In addition, in vitro fertilization technology 
(Deglincerti et al. 2016; Shahbazi et al. 2016) and pre-implantation in the mouse (Cockburn et al. 
2010) have contributed to our knowledge of pre-implantation events in humans. The development 
of the human placenta starts from the formation of the trophectoderm and the inner cell mass. At 
this developmental stage, the pre-implantation embryo is referred to as a blastocyst. 
Implantation starts around day 7 post conception (p.c.) when the blastocyst attaches and adheres 
to the uterine epithelium (Hertig 1956). How this is achieved is not clear.  Two groups cultured 
human embryos in vitro for 12–13 days p.c. and unveiled the self-organizing abilities in vitro 
attached human embryos (Deglincerti et al. 2016; Shahbazi et al. 2016). The presence of cell 
adhesion molecules including integrin, E-cadherin and L-selectin, on human oocytes, early 
embryos, and blastocysts, suggests that these molecules may play a role in embryo attachment and 
adhesion (Campbell et al. 1995). Following blastocyst attachment and adhesion, trophoblast cells 
undergo cell fusion to form the multinucleated syncytiotrophoblast (SCT), which invades the 
maternal uterine stroma. The mechanisms underlying the transition of cytotrophoblasts into SCTs 
remains largely unknown. The blastocyst eventually embeds itself into the stromal vasculature of 
the uterine lining (Norwitz et al. 2001; Boyd et al. 1970). With the embryo implanted in the uterus, 
epiblast and endoderm cells cavitate to form the amniotic cavity and yolk sac, respectively (Enders 
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1986). Around day 13 p.c., the cytotrophoblast cells underlying the SCT proliferate in columns 
and penetrate the cord of SCT, forming primary villi. Two days later, a connective tissue core 
derived from the extraembryonic mesenchyme invades the primary villi, transforming them into 
secondary villi (Boyd et al. 1970). Fetal blood vessels begin to form in the villi core by day 20 
p.c., marking the formation of tertiary villi, the first generation of which are the mesenchymal villi. 
These stages of the development of new villi are repeated throughout pregnancy. From this time 
onwards, placental villi are tertiary villi consisting of a vascular network, mesenchyme, 
cytotrophoblasts and SCTs. These 4 constituents together form the placental barrier (Boyd et al. 
1970). Around the 5th week p.c., mesenchymal villi begin to differentiate into immature 
intermediate villi with increased villous diameter and appearance of stromal channels, and later 
into stem villi by means of central stromal fibrosis (Castellucci et al. 1990). From around the 23th 
week p.c. until term, the mesenchymal villi differentiate into mature intermediate villi, from which 
highly capillarized terminal villi arise. These terminal villi, which begin to appear at around the 
25th week p.c. and account for nearly 40% of villous volume of the placenta at term, are the most 
effective structures for fetal-maternal diffusion exchange (Castellucci et al, 2000). Morphometric 
observations have shown that, although the villous growth slows down in late pregnancy, it 
continues to grow towards term (Boyed, 1984). If the maternal environment becomes unfavorable, 
the villous will continue branching past term. 
 
Structurally, the placenta is a complex and heterogeneous organ consisting of multiple different 
cell types that carry out varied functions. The functional unit of the placenta is the chorionic villus 
that consists of a stromal core, an inner layer of villous cytotrophoblasts (VCT) and an outer layer 
of multinucleated SCTs that cover the surface of the villous tree. The stromal core contains a range 
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of cells including macrophages (also called Hofbauer cells), mesenchymal stromal cells, 
fibroblasts, and fetal endothelial cells (Figure 1). Hofbauer cells are placental villous macrophages 
of fetal origin. scRNA-seq of the first-trimester placenta shows there are at least two subtypes of 
Hofbauer cells (Liu et al. 2018), which express genes involved in maintaining host defense, 
placental morphogenesis and homeostasis (Seval et al. 2007; Liu et al. 2018). Two populations of 
mesenchymal stromal cells were also identified from the single cell transcriptional profiling of 
first-trimester placental cells (Liu et al. 2018). One cell population likely plays a role in the 
regulation of cell adhesion and migration, whereas the other population in the development of 
blood vessels and the mesenchyme (Liu et al. 2018). Three fibroblast subtypes are identified by 
scRNA-seq analysis from the first-trimester placenta. Genes highly expressed in these cells are 
involved in endocrine signaling, endothelial cell migration and angiogenesis, and sodium and fluid 
homeostasis (Suryawanshi et al. 2018). Endothelial cells play an important physiological role in 
maintaining a vasodilated state in the fetoplacental vessels through the release of vasoactive 
substances, including nitric oxide. The villous cytotrophoblast (VCT) has been considered the 
proliferative stem-like cells. They either fuse to form SCTs during placental villous formation or 
penetrate the SCT to form extravillous trophoblast (EVT) columns in anchoring villi. scRNA-seq 
of the first-trimester placenta shows that one population of VCT cells express high levels of 
potentially important fusion genes, indicating that they may be the fusion-competent VCT cells 
(Liu et al. 2018). Single cell gene expression analysis of the first- and third trimester VCT cells 
indicates the continuous process of VCT to EVT differentiation throughout the pregnancy (Tsang 
et al. (2017; Suryawanshi et al. 2018). Invasion of the spiral arteries by EVTs leads to placental 
vascular remodeling in the early stages of the implantation process. The mechanisms involved in 
this evasion are still largely unknown. Recent scRNA-seq studies have shown that both the first- 
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and second-trimester EVTs expressed genes involved in invasion and immunomodulation, 
consistent with a likely role for EVTs in cellular invasion and anti-inflammatory in the early stage 
(Liu et al. 2018; Suryawanshi et al. 2018; Vento-Tormo et al. 2018). The SCTs cover the entire 
surface of villous trees and line in the intervillous space, where the maternal-fetal exchange of gas 
and nutrients occurs. scRNA-seq profiling revealed that these cells expressed genes involved in 
the production of gestational hormones, which support the fetal and placental development (Tsang 
et al. (2017; Suryawanshi et al. 2018).  Furthermore, the SCTs are involved in the immune 
tolerance of the fetus by the maternal immune system.  
Other cells may also exist at the interfacing of maternal-fetal surface. Uterine natural killer cells 
(uNK) constitute a major lymphocyte population in the uterus during early pregnancy. Their 
number increases around the time of implantation and remains high during the first trimester of 
pregnancy. uNK cells play a role in protecting the conceptus from maternal immune rejection and 
have been implicated in placental vascular remodeling (Sojka 2019). Decidual cells are a 
morphologically distinct cell class observed in the endometrium during implantation and early 
pregnancy. Functions of decidual cells are thought to regulate the trophoblast invasion and provide 
nutrition to the embryo (Kearns et al. 1983). 
The placenta plays a pivotal role in maintaining the health of both the fetus and the mother. Normal 
growth and development of placental structural components ensures a healthy pregnancy outcome, 
whereas alterations to placental structural components are associated with various pregnancy 
complications such as intrauterine growth restriction (IUGR), preeclampsia and preterm birth. 
These pregnancy complications and syndromes are associated with increased fetal and neonatal 
morbidity and have long-term negative impacts on the health of newborns. IUGR refers to a 
condition in which the fetus does not achieve the expected in utero growth potential. Fetal growth 
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is a complex process that involves genetic and environmental factors, nutrient availability from 
the mother, as well as hormones and growth factors.  The complications of IUGR include perinatal 
asphyxia, hypoglycemia, hypothermia, cerebral palsy, and pulmonary hypertension of the newborn 
(Mandruzzato et al. 2008). IUGR has many possible causes. A common cause is maternal factors 
such as maternal health, age, infection and behavioral habits. IUGR can also occur as the result of 
fetal malformations and chromosomal abnormalities. Preeclampsia is a medical syndrome that 
typically occurs after 20 weeks of gestation in pregnant women with previously normal blood 
pressure and affects both the mother and the unborn baby. Preeclampsia is characterized by 
hypertension and the presence of protein (0.3 g or more of protein in a 24-hour urine collection) 
in the urine in the mother (Steegers et al. 2010). While the etiology of preeclampsia is not fully 
understood, risk factors are proposed including hypertension and kidney disease, diabetes, obesity, 
a history of preeclampsia, aberrant placental implantation, and environmental and genetic factors. 
Preeclampsia has been linked to IUGR, as both conditions are assumed to be related to the similar 
placental disorder due to reduced trophoblast invasion (Kaufman et al. 2003). In fact, IUGR has 
been included among diagnostic criteria for severe preeclampsia (Tranquilli et al. 2014). The only 
effective treatment for preeclampsia is delivery of the fetus and placenta, leaving this disease one 
of the leading causes of preterm birth. Since preeclampsia is clinically and molecularly 
heterogeneous, advances in omics technologies, such as transcriptomics, epigenomics, proteomics 
and metabolomics, may help capture the complexity of the molecular mechanism of preeclampsia 
(Ching et al. 2014, 2015; Benny et al. 2020). 
Spontaneous preterm birth is defined as birth before 37 weeks of gestation, with an estimated 15 
million babies born preterm every year. It is the leading cause of death among children under 5 
years of age and is associated with an increased incidence of developmental delay, cerebral palsy, 
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and pulmonary and neurological disorders. The possible causes of preterm birth include maternal 
infections, decidual hemorrhage, multiple pregnancies, and chronic conditions such as 
hypertension and diabetes. It is important to know, that phenotypes such as IUGR, preeclampsia 
and preterm birth share comorbidities. Special efforts should be thus be paid to control for 
confounding in data analysis, in order to accurately ping-point the genomics-phenotype 
associations are truly due to the condition of interest, rather than other confounding factors.                                        
 
Although the etiology and pathogenesis of these above mentioned diseases are still not clear, the 
placental dysfunction is thought to be one of the main causes (Burton et al. 2018). Normal placental 
function is dependent on appropriate growth and development of its cells, which are 
heterogeneous, dynamic, and are determined by the precise regulation of gene expression. 
Consequently, alterations to placental gene expression are thought to be a major contributor to 
pregnancy pathologies. Previously, studies investigating the variation in bulk gene expression in 
placental tissues have been conducted in order to elucidate the molecular basis of placental 
development and pregnancy pathologies (Chappell et al. 2006; Sood et al. 2006). However, 
because the placenta is a complex and heterogeneous organ consisting of multiple cell types that 
have very different gene expression profiles, these bulk RNA analyses may miss transcriptional 
differences within a population of placental cells, and more importantly, they are unable to 
decipher the interactions among these cell types. Studying cellular heterogeneity is therefore 
critical to understand placenta cellular function in normal and disease states. Fortunately, recent 
advances in single-cell genomics, especially RNA sequencing (scRNA-seq) technologies, have 
enabled the characterization of gene expression of various cell types in placenta, simultaneously 
at single-cell resolution. 
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Single-cell RNA sequencing technologies  
Since the first scRNA-seq method was published in 2009 (Tang et al. 2009), this technology has 
been widely used to study dynamic gene expression at the single-cell level in diverse human 
tissues. The general workflow of scRNA-seq includes single-cell isolation, scRNA-seq library 
preparation, sequencing and computational analysis (Figure 1). Below we summarize and discuss 
several popular scRNA-seq methods. 
The first, and perhaps most important step in scRNA-seq is the isolation of viable, individual cells 
from fresh tissues. This can be technically challenging for complex tissues like the placenta, which 
consists of multiple cell types with various morphological and chemical properties. Methods for 
isolating cells include micromanipulation, limiting dilution, laser capture microdissection (LCM), 
fluorescence-activated cell sorting (FACS), magnetic associated cell separation (MACS), and 
microfluidics, each with its own strengths and weaknesses. Micromanipulation technique uses 
microscope-guided micropipettes to pick cells from samples with a small number of cells, such as 
early embryos (Guo et al. 2017). Micromanipulation is a simple and robust method, however, its 
throughput is low as cell transfer from the medium to tubes or plates increases the amount of time. 
Limiting dilution uses hand-pipettes to isolate single cells by the dilution of cell suspension (Fuller 
et al. 2001). This process is simple and cost-effective, but it is not as efficient as the probability of 
obtaining a single-cell based on the Poisson distribution. LCM utilizes a laser system aided by a 
computer to isolate individual cells or cell compartments from specific locations within solid tissue 
samples (Emmert-Buck et al. 1996). In combination with immunohistochemical staining, LCM 
allows access to cells in situ, which offers the opportunity to restrict expression analysis to 
spatially defined subareas within the tissue. Pavličev et al.used LCM method to enrich SCTs from 
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fresh-frozen sectioned human placentas and analyzed SCT-specific genes (Pavličev et al. 2017). 
The limitations of LCM include insufficient extraction of mRNAs due to incomplete capture of 
materials, and sometimes target cells are contaminated with undesired surrounding cells. In FACS 
method, the targeted cells tagged with fluorophore-conjugated monoclonal antibodies can be 
separated from one another depending on which fluorophore they have been stained with (Julius 
et al. 1972). While FACS is capable of isolating specific cell populations with high purity and 
throughput, it also requires a large starting number of the cells (more than 10,000 cells) in 
suspension and monoclonal antibodies specific to the cells of interest. In addition, this method can 
introduce oxidative stress on cells, which may result in their transcriptomic changes. In MACS 
method, fluorophores used in FACS are replaced with magnetic nanoparticles, allowing separation 
of target cells when exposed to a magnetic field. MACS method is much gentler and results in 
better cell viability than FACS. This is particularly important to placental scRNA-seq studies 
because placental trophoblast cells are highly vulnerable to damage during dissociation (Liu et al. 
2018). MACS method has been used in isolating multiple cell types from first- and second-
trimester placentas (Liu et al. 2018). Various microfluidic techniques are used for single-cell 
isolation. A widely used microfluidic technique is droplet-based microfluidics, such as Drop-seq 
and Chromium system from 10× Genomics. In the droplet-based systems, cells are individually 
encapsulated into a water-in-oil droplet, followed by the cDNA synthesis via reverse transcription, 
during which the cell barcode and the unique molecular identifiers (UMI) are incorporated into the 
cDNA molecule. The cDNAs from individual cells are amplified for library preparation and 
subsequently next-generation sequencing (Klein et al. 2015; Macosko et al. 2015; Zheng et al. 
2017). Droplet-based microfluidic systems are increasingly popular due to their scalability, low 
reagent consumption, and precise fluid control. Suryawanshi et al. compared two droplet-based 
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methods, Drop-seq and 10x Chromium platforms, for scRNA-seq analysis of human first-trimester 
placental cells. They found that although more genes were detected in the 10x Chromium method, 
there was a good correlation between the Drop-seq and 10x Chromium expression data 
(Suryawanshi et al. 2018). One limitation of droplet-based methods, however, is that it requires 
specific microfluidic devices and instruments for droplet sorting. The commercial droplet-based 
platforms have limited room for optimization or modification of cell capture conditions for specific 
samples.  
The scRNA-seq library preparation procedure involves several steps including the conversion of 
cellular RNA into first-strand cDNA by reverse transcription, second-strand cDNA synthesis by 
poly(A) tailing or by a template-switching approach, and cDNA amplification using PCR or by in 
vitro transcription (Chen et al. 2019). Then, amplified and tagged cDNAs from individual cells 
are pooled and sequenced. The Smart-seq2 approach generates full-length cDNA, thus has the 
advantage in allele-specific expression detection and alternative-splicing analysis (Picelli et al. 
2013). For example, Vento-Tormo et al. used Smart-seq2 method to investigate genes of the KIR 
family, which are polymorphic and highly homologous, in uNK cells from early pregnancy (6-14 
weeks) human placentas, and successfully mapped the single-cell reads to the corresponding 
donor- specific reference of KIR alleles (Vento-Tormo et al. 2018). Other methods combined with 
UMI or barcodes only capture either the 5’-end or 3’-end of the transcripts (Islam et al. 2011; 
Hashimshony et al. 2012). The main advantage of these methods is that they are more cost-efficient 
for transcriptome quantification of large cell numbers. However, these approaches are not suited 
for the isoform analysis and they are sub-optimal for single-nucleotide polymorphisms 
identification.  
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There are a few next generation sequencing platforms. Illumina sequencers are by far the most 
popular, with a claimed more than 70% dominance of the market, and have produced the majority 
of the publicly available human sequencing data. In 2015, BGI launched the BGISEQ-500 as an 
alternative to existing sequencing platforms, with lower sequencing cost. Sequencing performance 
comparison between the Illumina platform and the BGISEQ-500 showed that the two platforms 
have comparable sensitivity and accuracy in bulk RNA seq, small noncoding RNA seq, whole 
genome DNA seq, and scRNA-seq (Natarajan et al. 2019). The sequencing system chosen for a 
scRNA-seq experiment depends largely on the biological question being asked. Considerations for 
a sequencing experiment include total number of reads per cell, paired vs single read and the 
estimated desirable number of single cells to yield in each experiment. For example, 10x genomics 
recommend 50,000 read pairs per cell, with a targeted population up to 10,000 cells per sample. 
Single-read sequencing involves sequencing from only one end of DNA fragments in a library, 
while paired-end sequencing involves sequencing both ends of DNA. Single-read sequencing is 
faster and cheaper than paired-end sequencing and is mostly used to assess the abundancy of gene 
expression. Paired-end sequencing improves the ability to detect structural rearrangements 
(Rizzetto et al. 2017). Typically, paired-end reads (2 x 75 bp or 2 x 100 bp) are required for novel 
transcriptome assembly and annotation. Compared to the bulk RNA-seq method, scRNA-seq 
protocols have significantly more technical variations. The technical replicates can be used to 
assess and correct batch effects, however this is expensive given the cost of scRNA-Seq. 
Alternatively, some protocols use a set of synthetic RNAs with various lengths and GC content as 
spike-in controls (Brennecke et al. 2013). UMIs, which tag individual transcripts within a cell and 
thus can theoretically enable the estimation of absolute molecular counts, have also been used to 
reduce amplification bias (Kivioja et al. 2011). However, spike-ins and UMIs are not available for 
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every protocol. Spike-in RNAs can be used in protocols such as Smart-seq2 but are not compatible 
with droplet-based approaches, whereas UMIs are usually used in methods where only the 3’-ends 
of transcripts are sequenced, such as Drop-seq. 
Although the development of the experimental technologies and analytical methods have 
empowered the popularity of the single-cell RNA sequencing, one should be aware of the 
challenges. For example, scRNA-seq requires mechanical or enzymatic dissociation of the tissue, 
which could result in the loss of vulnerable cell types or even alter gene expression in cells. Thus, 
dissociation protocols must be optimized for the specific type of tissues of interest to minimize 
dissociation bias. A quality assessment of single cell preparation should be performed to ensure 
that cells are viable and fully dissociated into single cells before loading them onto the microfluidic 
chip. Two human placental scRNA-seq studies have shown that tissue dissociation may alter the 
frequencies of certain placental cell types (Liu et al. 2018; Suryawanshi et al. 2018). Variability 
in results may arise from both experimental and data analytical phases.  
 
Single Cell RNA-seq analysis pipelines 
The development of novel computational tools and analytical frameworks are closely coupled with 
single cell genomics technologies, in order to extract biological information. It is thus worthy to 
overview the computational pipelines and workflows, in the context of placenta scRNA-seq 
analysis.  
There is a growing list of new computational tools and pipelines, which were reviewed in detail 
elsewhere (Luecken et al. 2019; Vieth et al. 2019). A typical workflow includes two stages: (1) 
Data preprocessing and (2) Data analysis (Poirion et al. 2016). In data preprocessing, raw data are 
processed to obtain matrices of molecular counts or read counts, depending on whether unique 
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molecular identifiers (UMIs) were included in the library preparation protocol. This step consists 
of quality control, demultiplexing, alignments and quantification. Many benchmark studies have 
compared different aspects of the data preprocessing step and the effect of the choice of tools to 
downstream analysis (Vieth et al. 2019; Du et al. 2020). For example, using the splice-aware 
aligner STAR in conjunction with GENCODE annotation is indicated as the best practice for 
alignments in many studies. The data analysis step varies by the nature of the dataset and the 
specific goal of the study. In general, most computational pipelines include methods regarding (1) 
batch-correction, imputation, normalization and quality control; (2) feature selection and 
dimensionality reduction; (3) unsupervised clustering and supervised cell-type annotation; (4) 
differential expression analysis, gene set analysis and gene regulatory or protein-protein 
interaction network inference; (5) pseudotiming modeling, or trajectory analysis; (6) cell-cell 
communication analysis.  
Several single-cell analysis platforms encompassing all or most of methods mentioned above are 
available in R (Ji et al. 2016; McCarthy et al. 2017; Butler et al. 2018; Street et al. 2018; Cao et 
al. 2019; Iacono et al. 2019), Python (Wolf et al. 2018) or as Web servers (Gardeux et al. 2017; 
Zhu et al. 2017) (Table 2). Platforms in programmable environments provide more flexible 
manipulation of the data and methods, however it requires skills in programming language and/or 
UNIX commands. Graphical user interface platforms are convenient for non-expert users to build 
a single cell analysis workflow. It has advantages for quick exploratory analysis, although some 
may not scale toward larger datasets.  
It is worth noticing that single analytical results of cell studies often vary, due to differences in 
analytical framework. The increased number of bioinformatic methods proposed for analyzing and 
interpreting scRNA-seq data will only make unified analytical framework more challenging, if 
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ever possible. To address the variations due to analytical methods, one approach is to enforce the 
same standard pipeline and re-analyze, re-annotate the samples, which will be time consuming. 
Alternatively, methods of data integration could be used to analyze datasets from multiple 
experiments on the same tissue type. A series of single-cell data integration methods have been 
proposed to deal with such problems, such as LIGER, Harmony, scAlign (Welch et al. 2019; 
Korsunsky et al. 2019; Johansen and Quon 2019). Through data integration, we could enable an 
increase in sample size and standardize analytical frameworks across different datasets/studies 
which help us generalize observations (Lähnemann et al. 2020). In the context of placenta study, 
this will enable the meta atlas for placenta tissues, benefiting the subsequent experiments 
especially in cell type classification and rare cell identification. 
 
Human placental single cell RNA-seq studies 
 
During pregnancy, the placenta gene expression continuously changes in order to regulate the fetal 
growth, maintain immunological tolerance and to modulate metabolism according to pregnancy 
requirement. scRNA-seq has been used to reveal heterogeneity among various cell types in the 
human placenta, and to elucidate molecular interactions within a population of cells in different 
states. Thus far, seven scRNA-seq studies have been reported on placenta, with the samples 
ranging from as early as 6th week gestation to full term, in normal, preeclampsia or preterm birth 
conditions (Table 1). 
In the first-trimester, human placenta and decidua undergo dynamic changes to enable the 
establishment of a successful pregnancy. Four scRNA-seq studies so far have investigated the gene 
expression in human placentas from early pregnancy (Suryawanshi et al. 2018; Liu et al. 2018; 
Vento-Tormo et al. 2018; Sun et al. 2019). Gene profiling analyses of first trimester placenta 
revealed multiple genes involved in cell proliferation, adhesion, differentiation, inflammatory 
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responses, and metabolism, consistent with the findings from microarray study (Sitras et al. 2012). 
In addition, scRNA-seq gene profiling mapped the transcripts to the individual cells. These 
scRNA-seq studies also identified new cell subtypes and predicted interactions between cell types 
through the analysis of cell-to-cell gene expression variability. 
Suryawanshi et al. analyzed the gene expression in more than 20,000 cells from human placental 
villous and decidual tissues from early pregnancy (6-11 weeks). In order to differentiate fetal and 
maternal origin, they only included male fetus samples. 20 distinct cell populations (9 from villi 
and 11 from decidua) and uncovered previously unknown subtypes of the fibroblast-like (FB) cells 
were identified using unsupervised clustering and differential gene expression analyses. Gene 
profiling showed that all cell types identified in the villi sample expressed Y chromosome–encoded 
genes, indicating fetal origin of these villous cells, whereas female-specific gene XIST was only 
expressed in cell types identified in the decidua samples, indicative of their maternal origin. SCTs 
expressed genes involved in the production of gestational hormones, including CGA, CYP19A, 
HSD3B1, and GH2, that support the fetal and placental development. EVTs specifically express 
ECM genes, consistent with their role in invasion and mobility. Three villous FB subtypes were 
identified, which specifically express the genes associated with endothelial cell migration, 
angiogenesis, and the regulation of fluid homeostasis. Two decidual FB subtypes were also 
identified, which expressed the genes involved in cell adhesion and lipid metabolism. These 
observations indicate the influence of the microenvironment on FB cell fate determination. In 
addition, a proliferating and a resting NK subpopulation were differentiated through gene 
expression and gene ontology enrichment analyses. Receptor-ligand interaction analysis between 
and within villi and decidua showed abundantly expressed receptors and ligands for each cell type 
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of villi and decidua, providing insights into the cell-cell interactions in the fetomaternal 
microenvironment.  
Vento-Tormo et al. investigated the transcriptome of more than 70,000 cells from the maternal–
fetal interface between 6–14 weeks of gestation, and matched maternal peripheral blood cells from 
early pregnancy (6-14 weeks). Alignment of scRNA-seq reads with overlapping single nucleotide 
polymorphisms called from fetal and maternal genomic DNA showed that placental samples 
contained mostly fetal cells with some maternal macrophages, whereas most cells  from decidual 
samples except a few EVTs were of maternal origin. Unsupervised clustering and differential gene 
expression analyses identified two clusters of decidual fibroblast cells (PV1 and PV2), three 
clusters of decidual stromal cells (dS1, dS2 and dS3), and three subsets of decidual NK cells 
(dNK1, dNK2 and dNK3). The localization of decidual fibroblast cells and stromal cells was 
verified by immunohistochemistry as well as multiplexed single-molecule fluorescent in situ 
hybridization, and the presence of decidual NK cells was confirmed by flow cytometry. PV1 cells 
expressed high levels of genes involved in cell adhesion, while genes associated in tissue 
remodeling are higher in PV2 cells. All subsets of decidual NK cells express genes encoding 
proteins involved in anti-inflammatory roles, which suggests a ential role of these cells in 
regulating the extent of the trophoblast invasion. Expression analysis of the KIR gene family using 
the KIRid method indicates a likely function of dNK1 in the recognition and response to EVT. 
Trajectory modeling and psudotemporal ordering of cells predicted two distinct trophoblast 
differentiation pathways, with the decidual EVTs being at the end of the trajectory and expressing 
high levels of HLA-G. In addition, they developed a statistical tool named CellPhone to identify 
the specific interactions between decidual NK cells and invading fetal EVTs, maternal immune 
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and stromal cells. Using this tool, they predicted the ligand- receptor interactions that may control 
the differentiation processes of trophoblast cells to SCTs or EVTs (Vento-Tormo et al. 2018).  
Placental cellular lineage commitment occurs mainly during the first and second trimester 
pregnancies. The process of invasion of EVTs from anchoring villi into the uterine spiral arteries 
is also completed by 20 to 22 weeks of gestation in normal pregnancy (Pijnenborg et al. 1983). 
Incomplete EVT invasion and failure of spiral artery transformation by this time has been reported 
in preeclampsia  (Brosens et al. 1972), indicating that preeclampsia may be related to shallow EVT 
invasion. Liu et al. investigated the transcriptomic profile of sorted single cells from both first- (8 
weeks of gestation) and second-trimester (24 weeks of gestation) placentas. Unsupervised 
clustering analysis and differential gene expression analysis of maker genes revealed 14 subtypes 
of placental cells which vary with the different gestational stages. Specifically, they identified 
three CTB subtypes (CTB_8W_1, CTB_8W_2 and CTB_8W_3) from the first trimester placenta. 
These CTB subtypes have various degrees of proliferative capacity, which may serve as the pool 
of CTBs and progenitor cells of the STBs, respectively. CTB_8W_1 cells, with the least 
proliferative capacity, expressed high levels of potentially important fusion genes, indicating that 
they may be the fusion-competent CTB cells. 
They also identified five EVT subtypes (three EVT subtypes from 8-week placentas, EVT_8W, 
and two EVT subtypes from 24-week placentas, EVT_24W). Gene ontology analysis and 
immunostaining revealed that EVT_8W cells with proliferative potential were localized at the 
proximal end of the placental cell column, while EVT_8W cells involved in receptor activity 
regulation and the immune response were found to be at distal end of the placental cell column. 
Gene ontology analysis of EVT_24W cells showed that one subtype may be associated with the 
response to wounding, digestion and immunomodulation, while the other subtype related to growth 
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regulation, gonadotropin secretion and pregnancy. A pseudotime analysis of CTB_8W, EVT_8W 
and EVT_24W cells predicted a differentiation pathway of CTB_8W_2 cells to CTB_8W_3 cells 
and then to EVT_8W and EVT_24W cells, which is consistent with the study by Vento-Tormo et 
al. (Vento-Tormo et al. 2018). In addition, they identified two subtypes of macrophages (Macro_1 
and Macro_2) and mesenchymal stromal cells (Mes_1 and Mes_2) from the first trimester villous 
stromal core. Gene ontology analysis indicated a likely role of Mes_1 cells in the regulation of cell 
adhesion and migration, and of Mes_2 cells in the development of the mesenchyme and blood 
vessels. Gene ontology analysis of macrophages suggested that they may play a role in removal of 
dead cells or cellular debris during early placental development. Further, many polypeptide 
hormone genes were found to be expressed by the first-trimester SCTs, consistent with previous 
scRNA-seq studies (Tsang et al. 2017; Suryawanshi et al. 2018). Surprisingly, both the first- and 
second-trimester EVTs also expressed many hormone genes, indicating a role for these hormones 
in maintaining the fetal growth and the maternal adaptations to normal pregnancy (Liu et al. 2018).  
Recently, Sun et al. analyzed the gene expression in more than 7,000 cells from human placental 
villous and decidual tissues at 6-11 weeks of gestation. Using unsupervised clustering and 
differential gene expression analysis, they identified 5 major cell types (trophoblasts, stromal cells, 
hofbauer cells, antigen-presenting cells and endothelial cells) with unique crosstalk at the fetal-
maternal interface. Gene ontology enrichment analysis showed that the top enriched processes 
include cell proliferation and adhesion in trophoblasts, cell differentiation and signal transduction 
in stromal fibroblasts, inflammatory responses in Hofbauer cells, and cell migration and 
angiogenesis in endothelial cells. Cell-type specific upstream regulators were predicted by 
Ingenuity pathway analysis. In addition, a number of chemokine genes were found to have sex-
differential expression in trophoblasts and Hofbauer cells, suggesting a sexual dimorphism of 
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immune responses in the placenta (Sun et al. 2019). Although both microarray and bulk RNA-seq 
studies have shown sex-biased gene expression in human placentas at first-trimester and term 
(Sood, et al. 2006; Buckberry et al. 2014; Gonzalez et al. 2018), this is the first report by far that 
has investigated the sex-specific differences in single cell transcriptome of the placental cells.  
Given the vast differences in the types of cells and cell subtypes identified in these studies, it will 
be of interest to perform meta-analysis and comparative studies, to confirm the cell types that are 
either claimed novel, as well as the degrees of consistency among common cell types. 
 
Three studies have examined the human placental transcriptome during the third trimester. 
Pavličev et al. analyzed the gene expression profiles of full-term placental cells. They compared 
the single-cell transcriptomes with the tissue-level data and showed that scRNA-seq analysis 
recovered more than 4000 genes that were not detected in the tissue-level transcriptome, consistent 
with the view that scRNA-seq may reveal the expression profiles of rare cells. They identified five 
distinct clusters belonging to different types of decidual and fetal cells of utero-placental interface 
using hierarchical clustering and marker gene expression analysis. Among the five trophoblast 
clusters, the large clusters were identified as intravillous cytotrophoblast (iVCT), and the smaller 
cluster as EVT. These trophoblast clusters likely reflect the continuous differentiation process of 
cytotrophoblasts. The expression profiles of iVCT cells suggest that they are a very heterogeneous 
group and that the differentiation proceeds by individual cells in a different order. In addition to 
the identification of cell clusters, they inferred the cell-cell communication network at the 
maternal-fetal interface using public databases of ligand-receptor relationships based on the 
mRNA expression. A large number of interactions were found to be between decidual cells and 
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the SCT cells. Further, they showed that the cell-type specificity of G-protein-coupled receptor 
(GPCR) profiles may serve to biological characterize the cell type identity. 
Tsang et al. analyzed single-cell transcriptomes of more than 24,000 cells isolated from full-term 
and second trimester preeclamptic placentas. Clustering analysis by t-SNE identified diverse 
placental cell types and comparison of the ratio of transcripts carrying fetal-specific SNP alleles 
with those carrying maternal-specific SNP alleles showed that most clusters were of fetal origin. 
Gene profiling analysis showed that SCTs specifically expressed genes involved in the production 
of important gestational hormones, and EVTs expressed HLAs associated with maternal immune 
tolerance of the fetus with uNKs. In addition, they predicted the differentiation relationship of 
trophoblast cells using reclustering and pseudotime analyses. They showed that SCTs expressed 
high levels of the genes involved in cell fusion and identified several genes that could serve as 
regulators in SCT development. Analysis of the EVT developmental pathway revealed up-
regulation of various extracellular enzymes associated with invasion and migration. Importantly, 
comparison of transcriptomic profiling of biopsies taken from different sites of the placenta 
showed spatial heterogeneity, consistent with previous bulk tissue transcriptomic profiling (Sood 
et al. 2006). Furthermore, they integrated the single-cell-derived placental signature genes with 
maternal plasma-circulating RNA analysis to analyze the fetal and maternal cellular dynamics 
during pregnancy progression and suggested that the cellular pathology in early preeclampsia can 
be identified noninvasively (Tsang et al. 2017).  
More recently, Pique-Regi et al. carried out a comparative study to define individual cell-type–
specific gene signatures during physiologic and preterm labor (Pique-Regi et al. 2019). They 
analyzed cells from placental villi, basal plate, and chorioamniotic membranes of women with or 
without labor at term (38-40 weeks of gestation) and those with preterm labor (33-35 weeks of 
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gestation). Using differential gene expression analysis of marker genes, a new cluster of non-
proliferative interstitial cytotrophoblasts was identified in the placental villi, and the basal plate 
which is adjacent to the placental villi.  A new cluster of lymphatic endothelial decidual cells was 
also revealed in the chorioamniotic membranes using cell-type–specific gene signatures.  Gene 
enrichment analysis using clusterProfiler indicated that these lymphatic endothelial decidual cells 
may mediate the influx of immune cells into the chorioamniotic membranes. In addition, 
significant differences in transcriptional profiles were identified among placental cell types and 
between the term and preterm labor, with the largest number of differentially expressed genes in 
the maternal macrophages between the term labor and term no labor groups. Further, an in silico 
analysis in public datasets showed that the single-cell signatures of macrophages, monocytes, 
activated T cells, and fibroblasts is modulated in the circulation of women with preterm labor 
compared to gestational age-matched controls. These results suggested the feasibility of using 
single-cell signatures as biomarkers to non-invasively monitor the complex fetal and maternal 
cellular dynamics for normal or pathological conditions in pregnancy. Yet, additional studies are 
needed to characterize the transcriptional profiles of the very preterm labor (less than 32 weeks of 
gestation). 
 
Perspectives and conclusions 
Placenta is a very heterogeneous, blood-vessel rich organ with maternal and fetal origins and 
various cell types. The human placenta scRNA-seq studies reviewed here reveal that vast 
transcriptional differences exist among geolocations of placentas, between various cell types, 
gestational ages as well as in pregnancy diseases. These studies open up the possibilities to better 
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understand cellular networks and pathways in cells of normal and complicated pregnancies, which 
could help to discover the underlying causes of adverse pregnancy outcomes.  
However, one needs to be cautious before attempting scRNA-Seq studies using human placenta. 
Access to normal human placenta before delivery is challenging due to ethical concerns, limiting 
the kind of studies that can be conducted. Upon delivery, various factors need to be taken in 
consideration including hospital procedures, mode of delivery and sample sizes. Placenta grows 
and constantly adapts to the maternal environment to ensure a healthy pregnancy, thus static views 
of placenta cell proportions and gene expression are incorrect. Temporal, spatial and between 
individual variability have to be considered. Fresh samples are limited to deliveries and planning 
is critical. This also comes with challenges regarding deconvoluting disease state vs. batch 
variations. To get around these issues, single-nucleus RNA sequencing (snRNA-seq) has arisen as 
an alternative to single-cell methods. snRNA-seq does not require enzymatic digestion, which 
reduces dissociation artifacts. In addition, unlike scRNA-seq which requires the preparation of a 
live single cell suspension from fresh tissue which inevitably introduces batch effect, snRNA-seq 
can be used for frozen tissues, enabling single-cell gene profiling of archived clinical samples 
simultaneously, reducing batch effect and increasing power of the study by allowing for more 
biological replicates (Habib et al. 2017). 
Despite these technological and practical challenges, in the coming years, we expect to see more 
studies that will reveal the normal placenta developments throughout normal pregnancy and 
provide a more complete picture for a dynamic placenta atlas, such as those in Pediatric Cell Atlas 
(PCA) (Taylor et al. 2019). More single cell studies to investigate the molecular details of 
abnormalities in other pregnancy complications, such as gestational diabetes, could be interesting. 
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scRNA-seq studies that address the effect of lifestyle choices, such as smoking and alcohol use in 
pregnancy, will also pingpoint the biological changes in placentas at single cell level.  
Additionally, with the development of single cell technologies, other types of single cell omics 
studies, such as single cell epigenetics studies, as well as multi-omics single cell studies (scRNA-
seq, sc methylation and scATAC-Seq etc) will be very useful to delineate the coherent changes 
from epigenetic to transcriptomics level (Poirion et al.; Ortega et al. 2017). For example, single-
cell triple omics sequencing (scTrio-seq) (Hou et al., 2016), is a powerful technology that can 
simultaneously identify copy-number variations (CNVs), DNA methylome, and transcriptome of 
the same single mammalian cell. It was used to sequence 25 single cancer cells derived from a 
human hepatocellular carcinoma tissue sample and identified 2 subpopulations. The same team 
later applied this technology to colorectal cancer tumors and metastases from 10 individual 
patients, and showed that DNA methylation levels are consistent within lineages but differ 
substantially among clones (Bian et al., 2018). For more detailed experimental methods, the 
readers can refer to comment recently (Zhu et al., 2020). Another new technology that can 
potentially help understand the heterogeneity of placenta in situ, is the spatial transcriptomics, 
where single cell (or close to single cell ) resolution of gene expression data can be spatially 
mapped back to the tissue at 2D level (Moncada et al. 2020), where the 2D images can be stacked 
to reconstruct 3D images of the tissue. 
From the data analytics perspective, given the unique challenges of placenta, computational 
methods that can help automatically excluding blood cells due to experiments, decipher the 
maternal vs. fetal cell origins, and automatically annotate cell types in placenta will be critical for 
understanding the physiology and pathology of placenta. Besides pipelines and workflows for 
single cell RNA-Seq, tools and methods that aim at meta-analysis or comparative analysis of 
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different datasets will be valuable to uncover the development trajectory of placenta through 
gestational ages. Methods that integrate single cell multi-omics and multi-modal data, such as 
those handling spatial transcriptomics data, will be much needed for deeper characterization of 
placenta tissue. It will be interesting to see if and how the multi-omics data integration methods 
developed for bulk cell analysis can be extended to single cell (Huang et al. 2017). As the field 
moves forward with exponential growth of single cell genomics data, all methods will need to 
strive for accuracy and scalability, in order to be truly useful and withstand the test of time 
(Garmire et al. 2018).  In the end, advances in single-cell transcriptomics combined with 
computational analysis tools will enable significant improvement in both basic and clinical 
research related to the human placenta.  
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Figure Legend 
Figure 1. Single cell RNA-sequencing on placenta cells. The heterogeneity of placenta gene 
expression can be revealed by single cell RNA-sequencing (scRNA-seq) technology. The placenta 
tissue is first dissociated into a single cell suspension and cells are then individually encapsulated 
into a water-in-oil droplet, followed by the cDNA synthesis via reverse transcription, during which 
the cell barcode and the unique molecular identifiers (UMI) are incorporated into the cDNA 
molecule. The cDNAs from individual cells are amplified for library preparation, followed by 
next-generation sequencing. The sequences are then mapped by alignment algorithms and counted 
for those mapped to the reference transcriptome. The cell origin of the mapped reads can be 
identified by the cell barcode within them. As a result, a sequence read count matrix is generated 
over thousands of genes (rows) and thousands of single cells (columns). This count matrix is then 
subject to preprocessing and downstream bioinformatics analysis, such as clustering and pseudo-
time reconstruction among single cells, as shown in the figure. EVT, extravillous trophoblast; F, 
fibroblast; H, Hofbauer cell; SCT, syncytiotrophoblast; VCT, villous cytotrophoblast. 
HB
F
VCT
SCT
EVT
Table 1. Summary of current single cell RNA-seq studies on human placenta 
 
Gestational age 
(weeks) 
Tissue Number 
of cells 
Number of 
placenta 
Single cell 
isolation 
Platform Average 
reads 
length (bp) 
Mean 
Pair-end 
reads 
Reference 
6-11 Villous, 
decidual 
14,341  
6,754 
9 Enzyme 10x  
Drop-seq 
100 N/A Suryawanshi  
et al. (2018) 
6-14  Placenta, 
blood 
70,000 5 Enzyme, FACS 10x 
Smart-seq2 
75  1x106 Vento-Tormo  
et al. (2018) 
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Placenta 1,567 8 Enzyme, gradient 
centrifugation, 
MACS 
Smart-seq2 150  1x106 Liu et al.  
(2018) 
11-13 Placenta 7245 10 Enzyme 10x N/A N/A Sun et al.  
(2019) 
Term Placenta 87 2 Enzyme, , 
gradient 
centrifugation 
Fluidigm 75 3.65x106 Pavličev et 
al.  
(2017) 
Term 
(preeclampsia 
or healthy 
Placenta, 
blood 
24,000 8 Enzyme 10x 130 35800 Tsang et al.  
(2017) 
Term  
(with or without 
labor) 
preterm (33-35 
weeks) 
Placenta 79,906 9 Enzyme        10x N/A N/A Pique-Regi  
et al. (2019) 
 
Table 2. A list of platforms for single cell RNA-Seq analysis. 
 
Tool Platform URL Description Reference 
Granatum Web http://granatum.dcmb.med.umich.edu:8102
/?_state_id_=6e60464c6d7d66a3&tab=info 
A web-based comprehensive 
scRNA analysis framework 
with easy utilization 
Zhu et al. 
(2017) 
GranatumX Web http://35.222.3.147:34567/step/f6ba5588-
93c1-4507-8013-196273fb055b 
Updated version of Granatum 
with customized analysis 
modules 
Zhu et al. 
(2018) 
ASAP Web https://asap.epfl.ch/ Web-based automatic single-
cell analysis pipeline 
Gardeux et al. 
(2017) 
Seurat R https://satijalab.org/seurat/ A comprehensive scRNA-seq 
analysis framework, includes 
the anchor technology for data 
integration 
Butler et al. 
(2018) 
Monocle3 R https://cole-trapnell-
lab.github.io/monocle3/ 
A comprehensive scRNA-seq 
analysis framework, has good 
performance on pseudotime 
cell trajectories construction 
Cao et al. 
(2019) 
bigSCale2 R https://github.com/iaconogi/bigSCale2 A comprehensive scRNA-seq 
analysis framework, 
especially appropriate for 
large datasets 
Iacono et al. 
(2019) 
Scater R https://bioconductor.org/packages/release/b
ioc/html/scater.html 
A comprehensive scRNA-seq 
analysis framework, with a 
focus on quality control and 
visualization 
McCarthy et 
al. (2017) 
Slingshot R https://bioconductor.org/packages/release/b
ioc/html/slingshot.html 
Designed to model 
developmental trajectories in 
single-cell RNA sequencing 
data 
Street et al. 
(2018) 
TSCAN R https://github.com/zji90/TSCAN Designed to model 
developmental trajectories in 
single-cell RNA sequencing 
data 
Ji et al. (2016) 
Scanpy Python https://icb-scanpy.readthedocs-
hosted.com/en/stable/ 
A scalable scRNA-seq 
analysis toolkit, able to 
efficiently deal with datasets 
of more than one million cells, 
because of the Python-based 
implementation 
Wolf et al. 
(2018) 
 
